Development of Custom Immunobead Assays for Neoantigen-Associated Autoantibodies to Prognosticate Response to Immunotherapy in Advanced Lung Cancer

Speaker
  • Associate Professor, Rush University
    Biography
      Jeffrey A. Borgia, PhD. is a graduate of the Biochemistry Graduate program at the University of Minnesota where he trained with Dr. Theodore R. Oegema, Jr. on proteoglycan biosynthesis. Borgia then completed postdoctoral studies with Dr. Gregg B. Fields where he explored the production of matrix metalloproteinases by melanoma cells when adhered to synthetic 'mini-collagens' as well as tumor cell aggressiveness. In 2002, Borgia joined the faculty at Rush in the Department of Biochemistry where he continued some of his work on proteoglycan biochemistry, but later elected to focus on cancer biology and the development of novel diagnostic tests with Dr. John S. Coon IV in the Department of Pathology. He is currently continuing these studies with appointments in both the Department of Cell & Molecular Medicine as well as the Department of Pathology.

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    MAY 12, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 12, 2020 9:00 AM PDT
    NEW DATE: Date: May 12, 2020 Time: 9:00am PDT, 12:00pm EDT...
    APR 20, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 20, 2020 8:00 AM PDT
    This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
    JUN 30, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 30, 2020 9:00 AM PDT
    DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
    MAR 31, 2020 9:00 AM PDT
    C.E. CREDITS
    MAR 31, 2020 9:00 AM PDT
    DATE: March 31, 2020 TIME: 9:00am PT, 12:00pm ET HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2...
    Loading Comments...
    Show Resources